Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

European Patient Summary

Patient
Name: Λιναρδάκη, , Θεμιστοκλής,
DOB: 21-JAN-1974 (Age: 51)
Gender: male
ID: 5962-476889-7 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 18-JUN-2025

Problem list

Condition Onset Date Status
Metabolic syndrome X 18-Oct-2017 active
Chronic kidney disease stage 3 04-Jan-2017 active
Proteinuria due to type 2 diabetes mellitus 04-Jan-2017 active
Chronic kidney disease stage 2 13-May-2015 active
Microalbuminuria due to type 2 diabetes mellitus 13-May-2015 active
Disorder of kidney due to diabetes mellitus 01-Oct-2014 active
Chronic kidney disease stage 1 01-Oct-2014 active
Essential hypertension 01-Jul-1998 active
Prediabetes 26-Jan-1994 active
Anemia 26-Jan-1994 active

Medication list

Medication Since Form Dosage Reason
insulin isophane human 70 UNT/ML / insulin regular human 30 UNT/ML Injectable Suspension [Humulin] 2025-06-18 - Inject 10 units subcutaneously before breakfast and 10 units before dinner Prediabetes
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-06-18 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Hydrochlorothiazide 25 mg oral tablet 2025-06-18 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Lisinopril 10 mg oral tablet 2025-06-18 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 27-Nov-2024
Clostridium tetani toxoid antigen adsorbed only vaccine product 22-May-2024
Live attenuated Human alphaherpesvirus 3 only vaccine product 22-Nov-2023
SARS-CoV-2 mRNA vaccine 28-Apr-2021

Procedure History list

Procedure Date Reason
Medication reconciliation 20-Dec-2023 -
Depression screening 13-Dec-2023 -
Assessment of health and social care needs 13-Dec-2023 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 13-Dec-2023 -
Assessment of anxiety 03-Aug-2022 -
Screening for drug abuse 20-Mar-2019 -
Screening for domestic abuse 20-Mar-2019 -
Assessment of substance use 20-Mar-2019 -
Depression screening using PHQ-9 (Patient Health Questionnaire 9) score 13-Feb-2019 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Lifestyle education regarding hypertension 01-Jul-1998 Essential hypertension (disorder)
  • Maintain blood pressure below 130/80 mmHg to reduce risk of cardiovascular and renal complications.
  • Achieve at least 5% reduction in body weight to improve blood pressure control.
  • Limit sodium intake to less than 2.3 grams per day to support blood pressure management.
  • Engage in at least 150 minutes per week of moderate-intensity aerobic physical activity.
Diabetes self management plan 26-Jan-1994 Prediabetes
  • Patient will participate in a diabetes self-management program to improve knowledge and skills for prediabetes management.
  • Patient will achieve a 5% reduction in baseline body weight to reduce risk of progression to diabetes.
  • Patient will maintain hemoglobin A1c below 6.5% to prevent progression to diabetes.
  • Patient will engage in at least 150 minutes per week of moderate-intensity physical activity.
  • Patient will follow a diet low in refined carbohydrates and saturated fats to support glycemic control.

Vital Signs

Vital Signs 2025-06-18 2025-04-23
Body Height 187.3 cm 187.3 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} 3 {score}
Body Weight 101.8 kg 101.5 kg
Body mass index (BMI) [Ratio] 29 kg/m2 28.9 kg/m2
Diastolic Blood Pressure 78 mm[Hg] 82 mm[Hg]
Systolic Blood Pressure 102 mm[Hg] 95 mm[Hg]
Heart rate 95 /min 94 /min
Respiratory rate 12 /min 15 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 18-JUN-2025 Reference Range Unit
Glucose [Mass/volume] in Serum or Plasma 68.6 L 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Serum or Plasma 19.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Serum or Plasma 2.0 H 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Serum or Plasma 10.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Serum or Plasma 137.6 135 - 145 mmol/L
Potassium [Moles/volume] in Serum or Plasma 4.1 3.5 - 5 mmol/L
Chloride [Moles/volume] in Serum or Plasma 109.1 H 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Serum or Plasma 21.8 L 22 - 29 mmol/L
Appearance of Urine Cloudy urine
Odor of Urine Urine smell ammoniacal
Clarity of Urine Translucent
Color of Urine Brown color
Glucose [Mass/volume] in Urine by Test strip 2.3 H 0 - 0.8 mg/dL
Glucose [Presence] in Urine by Test strip ++
Bilirubin.total [Mass/volume] in Urine by Test strip 0.3 0.2 - 1 mg/dL
Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine
Ketones [Mass/volume] in Urine by Test strip 16.5 H 0 - 5 mg/dL
Ketones [Presence] in Urine by Test strip Urine ketone test = ++
Specific gravity of Urine by Test strip 1.0 L 1.005 - 1.03 {nominal}
pH of Urine by Test strip 6.6 4.6 - 7 pH
Protein [Mass/volume] in Urine by Test strip 243.1 H 0 - 150 mg/dL
Protein [Presence] in Urine by Test strip Urine protein test = ++
Nitrite [Presence] in Urine by Test strip Urine nitrite negative
Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative
Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative
Hemoglobin A1c/Hemoglobin.total in Blood 3.0 L 4.3 - 6.4 %
Glucose [Mass/volume] in Blood 68.6 L 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.4 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 5.3 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.1 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 109.1 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.8 L 22 - 29 mmol/L

Device Use

Device Date (since)
Blood glucose meter (physical object) 26-Jan-1994